Surgical treatment of mesenteric injuries is necessary to control hemorrhage, manage bowel injuries, and evaluate bowel perfusion. It has recently been suggested that some patients can be managed with transcatheter arterial embolization (TAE) for initial hemostasis. We present a hemodynamically unstable patient who was initially managed by TAE for traumatic mesenteric hemorrhage. A 60-year-old man was injured in a motor vehicle accident and transported to our facility. On arrival, the patient was hemodynamically stable, and had abdominal pain. Physical examination revealed a seatbelt sign on the lower abdomen. A contrast-enhanced computed tomography (CT) scan showed intra-abdominal hemorrhage, mesenteric hematoma, and a giant-pseudoaneurysm, but no intra-abdominal free air or changes in the appearance of the bowel wall. After the CT scan, his vital signs deteriorated and surgical intervention was considered, but TAE was performed to control the hemorrhage. After TAE, the patient was hemodynamically stable and had no abdominal tenderness. A follow-up CT scan was performed 2 days later which showed partial necrosis of the transverse colon and some free air. Resection of the injured transverse colon with primary anastomosis was performed. The patient improved and was discharged 35 days after injury. TAE can be effective as the initial hemostatic procedure in patients with traumatic mesenteric hemorrhage.
7 January 2021 in Scandinavian Journal of Trauma, Resuscitation and Emergency Medicine
Background: Unnecessary whole-body computed tomography (CT) may lead to excess radiation exposure. Serum D-dimer levels have been reported to correlate with injury severity. We examined the predictive value of serum D-dimer level for identifying patients with isolated injury that can be diagnosed with selected-region CT rather than whole-body CT. Methods: This single-center retrospective cohort study included patients with blunt trauma (2014–2017). We included patients whose serum D-dimer levels were measured before they underwent whole-body CT. “Isolated” injury was defined as injury with Abbreviated Injury Scale (AIS) score ≤ 5 to any of five regions of interest or with AIS score ≤ 1 to other regions, as revealed by a CT scan. A receiver operating characteristic curve (ROC) was drawn for D-dimer levels corresponding to isolated injury; the area under the ROC (AUROC) was evaluated. Sensitivity, specificity, positive predictive value, and negative predictive value were calculated for several candidate cut-off values for serum D-dimer levels. Results: Isolated injury was detected in 212 patients. AUROC was 0.861 (95% confidence interval [CI]: 0.815–0.907) for isolated injury prediction. Serum D-dimer level ≤ 2.5 μg/mL was an optimal cutoff value for predicting isolated injury with high specificity (100.0%) and positive predictive value (100.0%). Approximately 30% of patients had serum D-dimer levels below this cutoff value. Conclusion: D-dimer level ≤ 2.5 μg/mL had high specificity and high positive predictive value in cases of isolated injury, which could be diagnosed with selected-region CT, reducing exposure to radiation associated with whole-body CT.
Purpose: To evaluate the risk factors of non-diagnostic results based on cause of error in liver tumor biopsy. Materials and methods: This single-institution, retrospective study included 843 patients [445 men, 398 women; median age, 67 years] who underwent a total of 938 liver tumor biopsies between April 2018 and September 2022. An 18-G cutting biopsy needle with a 17-G introducer needle was used. Ultrasound was used as the first choice for image guidance, and computed tomography was alternatively or complementarily used only for tumors with poor ultrasound visibility. Non-diagnostic biopsies were divided into two groups depending on the cause of error, either technical or targeting error. Biopsies in which the biopsy needle did not hit the target tumor were classified as technical error. Biopsies in which insufficient tissue was obtained due to necrosis or degeneration despite the biopsy needle hitting the target tumor were classified as targeting error. This classification was based on pre-procedural enhanced-imaging, intro-procedural imaging, and pathological findings. Statistical analysis was performed using binary logistic regression. Results: The non-diagnostic rate was 4.6%. Twenty-six and seventeen biopsies were classified as technical and targeting errors, respectively. In the technical error group, tumor size ≤ 17 mm and computed tomography-assisted biopsy due to poor ultrasound visibility were identified as risk factors (p < 0.001 and p = 0.021, respectively), and the tumors with both factors had a significantly high risk of technical error compared to those without both factors (non-diagnostic rate: 17.2 vs 1.1%, p < 0.001). In the targeting error group, tumor size ≥ 42 mm was identified as a risk factor (p = 0.003). Conclusion: Tumor size ≤ 17 mm and computed tomography-assisted biopsy due to poor ultrasound visibility were risk factors for technical error, and tumor size ≥ 42 mm was a risk factor for targeting error in liver tumor biopsies.